<?xml version="1.0" encoding="UTF-8"?>
<p>While the mechanism of COVID‐19 induced gastrointestinal symptoms remains to be clarified, enteric symptoms may occur due to malabsorption secondary to direct damage of the invaded enterocyte in the setting of a viral infection.
 <xref rid="apt15779-bib-0018" ref-type="ref">
  <sup>18</sup>
 </xref> Furthermore, there is a recent case report of a possible SARS‐CoV‐2 gastrointestinal infection causing acute haemorrhagic colitis and signalling COVID‐19 disease.
 <xref rid="apt15779-bib-0031" ref-type="ref">
  <sup>31</sup>
 </xref> It is not clear if gastrointestinal symptom rates secondary to COVID‐19 differ in patients with IBD but if an IBD patients presents with worsening gastrointestinal symptoms, COVID‐19 infection should be considered as a differential.
</p>
